09:16 AM EDT, 09/08/2025 (MT Newswires) -- Health care stocks were edging higher premarket Monday, with the Health Care Select Sector SPDR Fund ( XLV ) advancing by 0.1% and the iShares Biotechnology ETF (IBB) up 0.3%.

Premier (PINC) is being targeted for a potential go-private deal by Patient Square Capital, Bloomberg reported, citing people familiar with the matter. Shares of Premier were up more than 8% pre-bell.

Ideaya Biosciences ( IDYA ) shares were up more than 1% after the company said interim phase 2 data for darovasertib in the neoadjuvant setting for primary uveal melanoma showed ocular tumor shrinkage, reduced radiation doses to critical eye structures, and improved vision.

Rapport Therapeutics ( RAPP ) shares were surging by more than 191% after the company said a phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint.